Download PDF
Thromb Haemost 2016; 115(02): 353-360
DOI: 10.1160/th15-03-0227
Blood Cells, Inflammation and Infection
Schattauer GmbH

Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention

Bert Rutten
1   Department of Clinical Chemistry and Haematology, UMC Utrecht, Utrecht, the Netherlands
,
Mark Roest
1   Department of Clinical Chemistry and Haematology, UMC Utrecht, Utrecht, the Netherlands
,
Elizabeth A. McClellan
2   Department of Bioinformatics, Erasmus UMC, Rotterdam, the Netherlands
8   Department of Nephrology and the Einthoven Laboratory for Experimental Vascular Medicine, Leiden UMC, Leiden, the Netherlands
,
Jan W. Sels
3   Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands
,
Andrew Stubbs
2   Department of Bioinformatics, Erasmus UMC, Rotterdam, the Netherlands
,
J. Wouter Jukema
4   Department of Cardiology, Leiden UMC, Leiden, the Netherlands
,
Pieter A. Doevendans
5   Department of Experimental Cardiology, UMC Utrecht, Utrecht, the Netherlands
,
Johannes Waltenberger
6   Department of Cardiology, Maastricht UMC, Maastricht, the Netherlands
,
Anton-Jan van Zonneveld
7   Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany
,
Gerard Pasterkamp
5   Department of Experimental Cardiology, UMC Utrecht, Utrecht, the Netherlands
,
Philip G. de Groot   #
1   Department of Clinical Chemistry and Haematology, UMC Utrecht, Utrecht, the Netherlands
,
Imo E. Hoefer   #
5   Department of Experimental Cardiology, UMC Utrecht, Utrecht, the Netherlands
› Author Affiliations Financial support: This research was performed within the framework of the Center for Translational Molecular Medicine and supported by the Dutch Heart Foundation.
Further Information

Publication History

Received: 14 March 2015

Accepted after major revision: 24 August 2015

Publication Date:
22 November 2017 (online)

Also available at
    Permissions and Reprints

Summary

Monocyte recruitment to damaged endothelium is enhanced by platelet binding to monocytes and contributes to vascular repair. Therefore, we studied whether the number of platelets per monocyte affects the recurrence of adverse events in patients after percutaneous coronary intervention (PCI). Platelet-monocytes complexes with high and low median fluorescence intensities (MFI) of the platelet marker CD42b were isolated using cell sorting. Microscopic analysis revealed that a high platelet marker MFI on monocytes corresponded with a high platelet density per monocyte while a low platelet marker MFI corresponded with a low platelet density per monocyte (3.4 ± 0.7 vs 1.4 ± 0.1 platelets per monocyte, P=0.01). Using real-time video microscopy, we observed increased recruitment of high platelet density monocytes to endothelial cells as compared with low platelet density monocytes (P=0.01). Next, we classified PCI scheduled patients (N=263) into groups with high, medium and low platelet densities per monocyte and assessed the recurrence of adverse events. After multivariate adjustment for potential confounders, we observed a 2.5-fold reduction in the recurrence of adverse events in patients with a high platelet density per monocyte as compared with a low platelet density per monocyte [hazard ratio=0.4 (95 % confidence interval, 0.2–0.8), P=0.01]. We show that a high platelet density per monocyte increases monocyte recruitment to endothelial cells and predicts a reduction in the recurrence of adverse events in patients after PCI. These findings may imply that a high platelet density per monocyte protects against recurrence of adverse events.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

Monocytes - platelets - adverse events - percutaneous coronary intervention

# Prof. P.G. de Groot and Dr. I.E. Hoefer contributed equally to this study.


 

  • References

  • 1 Cuculi F, Lim C, Banning A. Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?. Heart 2010; 96: 736-740.
    CrossrefPubMedGoogle Scholar
  • 2 Ganesha Babu G, Malcolm Walker J, Yellon D. et al. Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for car-dioprotection. Eur Heart J 2010; 32: 23-31.
    PubMedGoogle Scholar
  • 3 Lansky A, Stone G. Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention. Circulation Cardiovasc Interven 2010; 03: 602-610.
    PubMedGoogle Scholar
  • 4 Levitsky S. Protecting the Myocardial Cell During Coronary Revascularisation. Circulation 2006; 114: I-339-I-343.
    CrossrefPubMedGoogle Scholar
  • 5 Murray P, Wynn T. Protective and pathogenic functions of macrophage subsets. Nature Rev Immunol 2011; 11: 723-737.
    CrossrefPubMedGoogle Scholar
  • 6 Fujiyama S. Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothe-lium in a Monocyte Chemoattractant Protein-1-Dependent Manner and Accelerate Reendothelialisation as Endothelial Progenitor Cells. Circulation Res 2003; 93: 980-989.
    CrossrefPubMedGoogle Scholar
  • 7 Moldovan N, Goldschmidt-Clermont P, Parker-Thornburg J. et al. Contribution of Monocytes/Macrophages to Compensatory Neovascularisation: The Drilling of Metalloelastase-Positive Tunnels in Ischaemic Myocardium. Circulation Res 2000; 87: 378-384.
    CrossrefPubMedGoogle Scholar
  • 8 Asahara T, Bauters C, Pastore C. et al. Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialisation and Attenuates Intimal Hyper-plasia in Balloon-Injured Rat Carotid Artery. Circulation 1995; 91: 2793-2801.
    CrossrefPubMedGoogle Scholar
  • 9 Nahrendorf M, Pittet M, Swirski F. Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction. Circulation 2010; 121: 2437-2445.
    CrossrefPubMedGoogle Scholar
  • 10 Nahrendorf M, Swirski F, Aikawa E. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007; 204: 3037-3047.
    CrossrefPubMedGoogle Scholar
  • 11 Rehman J. Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors. Circulation 2003; 107: 1164-1169.
    CrossrefPubMedGoogle Scholar
  • 12 Urbich C. Relevance of Monocytic Features for Neovascularisation Capacity of Circulating Endothelial Progenitor Cells. Circulation 2003; 108: 2511-2516.
    CrossrefPubMedGoogle Scholar
  • 13 Kalka C, Masuda H, Takahashi T. et al. Transplantation of ex vivo expanded en-dothelial progenitor cells for therapeutic neovascularisation. Pro Natl Acad Sci 2000; 97: 3422-3427.
    CrossrefPubMedGoogle Scholar
  • 14 Rookmaaker M. Endothelial Progenitor Cells: Mainly Derived From the Mono-cyte/Macrophage-Containing CD34- Mononuclear Cell Population and Only in Part From the Hematopoietic Stem Cell-Containing CD34+ Mononuclear Cell Population * Response. Circulation 2003; 108: 150e-150.
    CrossrefPubMedGoogle Scholar
  • 15 Davis C, Fischer J, Ley K. et al. The role of inflammation in vascular injury and repair. J Thromb Haemost 2003; 01: 1699-1709.
    CrossrefPubMedGoogle Scholar
  • 16 Morrell C, Aggrey A, Chapman L. et al. Emerging roles for platelets as immune and inflammatory cells. Blood 2014; 123: 2759-2767.
    CrossrefPubMedGoogle Scholar
  • 17 Leppanen A, Yago T, Otto V. et al. Model Glycosulfopeptides from P-selectin Glycoprotein Ligand-1 Require Tyrosine Sulfation and a Core 2-branched O-Glycan to Bind to L-selectin. J Biol Chem 2003; 278: 26391-26400.
    CrossrefPubMedGoogle Scholar
  • 18 Huo Y, Ley K. Role of Platelets in the Development of Atherosclerosis. Trends Cardiovasc Med 2004; 14: 18-22.
    CrossrefPubMedGoogle Scholar
  • 19 Huo Y, Schober A, Forlow S. et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2002; 09: 61-67.
    CrossrefPubMedGoogle Scholar
  • 20 da Costa Martins P. Platelet-Monocyte Complexes Support Monocyte Adhesion to Endothelium by Enhancing Secondary Tethering and Cluster Formation. Ar-terioscl Thromb Vasc Biol 2004; 24: 193-199.
    CrossrefPubMedGoogle Scholar
  • 21 Sixma J, de Groot P, van Zanten H. et al. A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb Res 1998; 92: S43-S46.
    CrossrefPubMedGoogle Scholar
  • 22 Hoefer I, Sels J, Jukema J. et al. Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study. Clin Res Cardiol 2013; 102: 847-856.
    CrossrefPubMedGoogle Scholar
  • 23 Hoefer I. Arteriogenesis Proceeds via ICAM-1/Mac-1- Mediated Mechanisms. Circulation Res 2004; 94: 1179-1185.
    CrossrefPubMedGoogle Scholar
  • 24 Zhang Y, Liu D, Chen X. et al. Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration. Mol Cell 2010; 39: 133-144.
    CrossrefPubMedGoogle Scholar
  • 25 Heil M, Ziegelhoeffer T, Pipp F. et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol 2002; 283: H2411-H2419.
    PubMedGoogle Scholar
  • 26 Bernardo A, Bakk C, Nolasco L. et al. Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J Thromb Haemost 2005; 03: 562-570.
    CrossrefPubMedGoogle Scholar
  • 27 De Maeyer B, De Meyer S, Feys H. et al. The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo. J Thromb Haemost 2010; 08: 2305-2312.
    CrossrefPubMedGoogle Scholar
  • 28 Urra X, Villamor N, Amaro S. et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cerebral Blood Flow Metabol 2009; 29: 994-1002.
    CrossrefPubMedGoogle Scholar
  • 29 Wrigley BJ, Shantsila E, Tapp LD. et al. Increased formation of monocyte-pla-telet aggregates in ischaemic heart failure. Circulation Heart Fail 2013; 06: 127-135.
    CrossrefPubMedGoogle Scholar
  • 30 Passacquale G, Vamadevan P, Pereira L. et al. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PloS one 2011; 06: e25595.
    CrossrefPubMedGoogle Scholar